6,495 Shares in Cabot Corporation $CBT Purchased by United Capital Financial Advisors LLC

United Capital Financial Advisors LLC bought a new position in shares of Cabot Corporation (NYSE:CBTFree Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 6,495 shares of the specialty chemicals company’s stock, valued at approximately $590,000.

A number of other institutional investors have also added to or reduced their stakes in CBT. BlackRock Inc. purchased a new stake in Cabot during the second quarter worth $633,302,000. Bank of America Corp DE purchased a new position in shares of Cabot in the 2nd quarter valued at $150,772,000. Norges Bank bought a new position in shares of Cabot in the 4th quarter worth $49,662,000. Bank of New York Mellon Corp bought a new position in shares of Cabot in the 2nd quarter worth $57,445,000. Finally, AQR Capital Management LLC lifted its stake in shares of Cabot by 123.0% during the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after purchasing an additional 478,702 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Stock Down 1.1%

Cabot stock opened at $82.72 on Tuesday. Cabot Corporation has a 1-year low of $58.33 and a 1-year high of $94.53. The business has a fifty day moving average price of $87.46 and a 200-day moving average price of $81.29. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. The stock has a market capitalization of $4.27 billion, a price-to-earnings ratio of 23.30, a PEG ratio of 10.98 and a beta of 0.84.

Cabot (NYSE:CBTGet Free Report) last announced its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The company had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. During the same period in the prior year, the company posted $1.90 EPS. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities research analysts forecast that Cabot Corporation will post 6.35 EPS for the current fiscal year.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be given a $0.4725 dividend. This represents a $1.89 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Friday, August 28th. Cabot’s dividend payout ratio (DPR) is presently 53.24%.

Insider Buying and Selling

In related news, CEO Sean D. Keohane sold 134,895 shares of Cabot stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $85.00, for a total value of $11,466,075.00. Following the completion of the sale, the chief executive officer directly owned 404,134 shares in the company, valued at $34,351,390. This trade represents a 25.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In the last ninety days, insiders have sold 229,597 shares of company stock valued at $19,646,746. 3.08% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CBT. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, August 9th. JPMorgan Chase & Co. increased their price target on shares of Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a research report on Friday, August 7th. Mizuho raised their price target on shares of Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. Finally, UBS Group reduced their price objective on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research note on Wednesday, August 5th. Two investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Cabot presently has an average rating of “Hold” and a consensus target price of $89.00.

Read Our Latest Stock Report on CBT

About Cabot

(Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Recommended Stories

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.